N@N

Amyris Technology Performs Successfully at Industrial Scale

^{Published on 2011-02-22 13:05:40 - Market Wire}
 

EMERYVILLE, Calif.--([ BUSINESS WIRE ])--Amyris, Inc. (NASDAQ: AMRS) announced today that it has completed multiple runs of its fermentation process using Amyris engineered yeast to produce Biofenea", Amyris renewable farnesene, in 100,000 and 200,000 liter capacity fermentors. These runs were completed through contract manufacturing operations in North America and Europe. The results of these fermentation runs, including yields, were consistent with previous runs at smaller scale.

"These experiences have given us valuable insight into how our yeast will perform at commercial scale, and the fact that our yeast performance translated from lab to industrial scale is a strong testament to our technology and the capability of our scientists and engineers."

aThese runs significantly de-risk our operations at industrial scale,a said Jeff Lievense, senior vice president of process development and manufacturing at Amyris. aThese experiences have given us valuable insight into how our yeast will perform at commercial scale, and the fact that our yeast performance translated from lab to industrial scale is a strong testament to our technology and the capability of our scientists and engineers.a

Amyris expects to commence commercial production of Biofene in the second quarter of 2011 and ramp production through manufacturing arrangements with entities including Biomin and Tate & Lyle. In addition, Amyris and Grupo So Martinho, a leading sugar and ethanol producer in Brazil, have commenced site preparation on their joint venture production facility at Usina So Martinho. All of these facilities will utilize fermentors with capacities ranging between 100,000 and 600,000 liters.

About Amyris

Amyris is an integrated renewable products company focused on providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules - flexible building blocks which can be used in a wide range of products. Amyris is commercializing these products both as No Compromise® renewable ingredients in cosmetics, flavors and fragrances, polymers, lubricants and consumer products, and also as No Compromise renewable diesel and jet fuel. Amyris Brasil S.A., a subsidiary of Amyris, oversees the establishment and expansion of Amyris's production in Brazil. Amyris also has fuel distribution capabilities in the United States through its subsidiary, Amyris Fuels LLC. More information about Amyris is available at [ www.amyris.com ].

Forward-Looking Statements

This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as statements regarding the commencement and scale of commercial production of Biofene) that involve risks and uncertainties. These statements are based on managementa™s current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays in production and commercialization of products and other risks detailed in the aRisk Factorsa section of Amyrisa™s final prospectus for its initial public offering, as filed on September 28, 2010 pursuant to Rule 424(b) under the Securities Act of 1933, and its quarterly report on Form 10-Q filed on November 10, 2010. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.